Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Belite Bio Inc ADR (BLTE)

Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Belite Bio Inc ADR 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 USA

www.belitebio.com Employees: 25 P: 858-246-6240

Sector:

Medical

Description:

Belite Bio Inc. is a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration, such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease, and metabolic diseases. Belite Bio Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 5,818,951
Enterprise Value, $K 5,787,271
Shares Outstanding, K 37,515
Float, K 32,529
% Float 86.71%
Short Interest, K 330
Short Float 0.88%
Days to Cover 1.61
Short Volume Ratio 0.43
% of Insider Shareholders 13.29%
% of Institutional Shareholders 0.53%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -36,140 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,690 K
EBIT, $ -67,600 K
EBITDA, $ -67,150 K

Growth:

1-Year Return 184.66%
3-Year Return 434.26%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.65 on 11/10/25
Next Earnings Date 03/16/26
Earnings Per Share ttm -1.92
EPS Growth vs. Prev Qtr -30.00%
EPS Growth vs. Prev Year -132.14%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BLTE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -34.29%
Return-on-Assets % -33.05%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 18.02
Book Value/Share 8.61
Interest Coverage -1,806.00
60-Month Beta -1.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar